Boriss Strumfs

16 Dzirciema Street
Riga, RIX LV1007, Latvia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Morphological and Immunohistochemical Characteristics of Liver Inflammation in Patients with a History of COVID-19.

Morphological and Immunohistochemical Characteristics of Liver Inflammation in Patients with a History of COVID-19.

Journal: Viruses

Published: November 13, 2025

Tumour Microenvironment: The General Principles of Pathogenesis and Implications in Diffuse Large B Cell Lymphoma.

Tumour Microenvironment: The General Principles of Pathogenesis and Implications in Diffuse Large B Cell Lymphoma.

Journal: Cells

Published: April 29, 2024

Non-Aziridination Approaches to 3-Arylaziridine-2-carboxylic Acid Derivatives and 3-Aryl-(aziridin-2-yl)ketones.

Non-Aziridination Approaches to 3-Arylaziridine-2-carboxylic Acid Derivatives and 3-Aryl-(aziridin-2-yl)ketones.

Journal: International journal of molecular sciences

Published: May 01, 2022

Immunohistochemical Profile of Parathyroid Tumours: A Comprehensive Review.

Immunohistochemical Profile of Parathyroid Tumours: A Comprehensive Review.

Journal: International journal of molecular sciences

Published: April 17, 2022

An Easy Route to Aziridine Ketones and Carbinols.

An Easy Route to Aziridine Ketones and Carbinols.

Journal: International journal of molecular sciences

Published: November 03, 2021

Molecular profile of parathyroid tissues and tumours: a heterogeneous landscape.

Molecular profile of parathyroid tissues and tumours: a heterogeneous landscape.

Journal: Polish journal of pathology : official journal of the Polish Society of Pathologists

Published: October 28, 2021

3-Arylaziridine-2-carboxylic Acid Derivatives and (3-Arylaziridin-2-yl)ketones: The Aziridination Approaches.

3-Arylaziridine-2-carboxylic Acid Derivatives and (3-Arylaziridin-2-yl)ketones: The Aziridination Approaches.

Journal: International journal of molecular sciences

Published: August 11, 2021

A Novel Aziridine-based Bruton's Tyrosine Kinase Inhibitor Induces Apoptosis Through Down-regulation of p65/RelA Phosphorylation on Serine 536 and ERK1/2 in Mantle Cell Lymphoma.

A Novel Aziridine-based Bruton's Tyrosine Kinase Inhibitor Induces Apoptosis Through Down-regulation of p65/RelA Phosphorylation on Serine 536 and ERK1/2 in Mantle Cell Lymphoma.

Journal: Anticancer research

Published: July 29, 2016

Showing 1-8 of 8

Last Updated: 09/26/2026